Highlights
NASDAQ: EARS       Auris Medical
Last Price Today's Change   Day's Range   Trading Volume
0.844   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):3,149,115
4 Weeks Range:0.761 - 1.30
4 Weeks Price Volatility (%):
64.92%
52 Weeks Range:0.65 - 1.84
52 Weeks Price Volatility (%):
45.87%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Auris Medical Holding AG is a clinical-stage biopharmaceutical company. The company develops novel products for the treatment of inner ear disorders. It has two projects in advanced clinical development Keyzilen for the treatment of acute inner ear tinnitus and AM-111 for the treatment of acute inner ear hearing loss. Auris Medical is developing Keyzilen for the treatment of acute inner ear (peripheral) tinnitus following traumatic cochlear injury or otitis media (middle ear infection). Keyzilen contains Esketamine hydrochloride, an N-Methyl-D-Aspartate (NMDA) receptor antagonist, formulated in a biocompatible and fully biodegradable gel. Auris Medical is developing AM-111 for the treatment of acute inner ear (sensorineural) hearing loss (ASNHL).

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

9266 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 KSMT 9.630.00 
 HIPS 11.6650.00 
 HONE 9.260.00 
 ENZL 61.2020.00 
 KOD 97.740.00 
 UPRO 57.190.00 
 COLD 36.920.00 
 ALYA 2.740.00 
 CIGI 71.510.00 
 AXNX 50.320.00